Active treatments are a rational approach for hepatocellular carcinoma in elderly patients

World Journal of Gastroenterology

Volumn 19, Issue 24, 2013, Pages 3831-3840

  Suda, Takeshi ^a   Nagashima, Aiko ^a   Takahashi, Shyunsaku ^a   Kanefuji, Tsutomu ^a   Kamimura, Kenya ^a   Tamura, Yasushi ^a   Takamura, Masaaki ^a   Igarashi, Masato ^a   Kawai, Hirokazu ^a   Yamagiwa, Satoshi ^a   Nomoto, Minoru ^a   Aoyagi, Yutaka ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Active intervention; Hepatocellular carcinoma; Life expectancy; Population aging; Survival

Indexed keywords

ALCOHOL; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER SURVIVAL; CANCER THERAPY; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; INTERVENTIONAL RADIOLOGY; LIFE EXPECTANCY; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROWAVE RADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL PHLEBOGRAPHY; PROTON RADIATION; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME;

EID: 84879585830     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i24.3831     Document Type: Article

References (19)

1. Available from: URL: http://www.stat.go.jp/english/in-dex.htm
2. Available from: URL: http://www.mhlw.go.jp/english/ database/db-hw/index.html
3. Available from: URL: http://www.stat.go.jp/data/sekai/02.htm
4. Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years. Zhonghua Yixve Zazhi 2006; 119: 1151-1156 [PMID: 16863605]
5. Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. J Am Coll Cardiol 2009; 54: 1303-1308 [PMID: 19778673 DOI: 10.1016/j.jacc.2009.07.013]
6. Asano S, Hara T, Haisa T, Okamoto K, Kato T, Ohno H, Ha-suo K, Kondo T. Outcomes of 24 patients with subarachnoid hemorrhage aged 80 years or older in a single center. Clin Neurol Neurosurg 2007; 109: 853-857 [PMID: 17868980 DOI: 10.1016/j.clineuro.2007.08.001]
7. Johansson M, Cesarini KG, Contant CF, Persson L, Enblad P. Changes in intervention and outcome in elderly patients with subarachnoid hemorrhage. Stroke 2001; 32: 2845-2949 [PMID: 11739985 DOI: 10.1161/hs1201.099416]
8. Fagin AM, Cipolle MD, Barraco RD, Eid S, Reed JF, Li PM, Pasquale MD. Odontoid fractures in the elderly: should we operate? J Trauma 2010; 68: 583-586 [PMID: 19996794 DOI: 10.1097/TA.0b013e3181b23608]
9. Clinical Practice Guidelines for Hepatocellular Carcinoma -The Japan Society of Hepatology 2009 update. Hepatol Res 2010; 40 Suppl 1: 2-144 [PMID: 20586808 DOI: 10.1111/ j.1872-034X.2010.00650.x]
10. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology 2003; 50: 2022-2027 [PMID: 14696457]
11. Chlebowski RT, Tong M, Weissman J, Block JB, Ramming KP, Weiner JM, Bateman JR, Chlebowski JS. Hepatocel-lular carcinoma. Diagnostic and prognostic features in North American patients. Cancer 1984; 53: 2701-2706 [PMID: 6326991]
12. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988; 48: 7314-7318 [PMID: 2847868]
13. Calvet X, Bruix J, Ginés P, Bru C, Solé M, Vilana R, Rodés J. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 1990; 12: 753-760 [PMID: 2170267 DOI: 10.1002/hep.1840120422]
14. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992; 16: 112-117 [PMID: 1377657 DOI: 10.1002/hep.1840160119]
15. Hazama H, Omagari K, Matsuo I, Masuda J, Ohba K, Sa-kimura K, Kinoshita H, Isomoto H, Murase K, Kohno S. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepatogas-troenterology 2001; 48: 1692-1696 [PMID: 11813602]
16. Thornton RH, Covey A, Petre EN, Riedel ER, Maluccio MA, Sofocleous CT, Brody LA, Getrajdman GI, D'Angelica M, Fong Y, Brown KT. A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years. Cancer 2009; 115: 5000-5006 [PMID: 19642175 DOI: 10.1002/cncr.24556]
17. Dohmen K, Shirahama M, Shigematsu H, Irie K, Ishibashi H. Optimal treatment strategy for elderly patients with hepa-tocellular carcinoma. J Gastroenterol Hepatol 2004; 19: 859-865 [PMID: 15242487 DOI: 10.1111/j.1440-1746.2003.03306.x]
18. Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepa-tectomy. J Gastrointest Surg 2009; 13: 1627-1635 [PMID: 19506976 DOI: 10.1007/s11605-009-0933-4]
19. Colloca G, Santoro M, Gambassi G. Age-related physiologic changes and perioperative management of elderly patients. Surg Oncol 2010; 19: 124-130 [PMID: 20004566 DOI: 10.1016/ j.suronc.2009.11.011]